Novo Nordisk, Roche, GSK, Johnson & Johnson: the biggest names in pharma have moved off SAS. This post breaks down what's actually driving that shift, what open source delivers beyond cost savings, and what separates a successful transition from one that stalls.

The pharma and life sciences dilemma: Stick with SAS or move to R? Explore key insights in our detailed review.

A comprehensive guide on how to seamlessly transition from SAS to R (and integrate SAS data into R) for efficient data analysis.

If you're looking to switch data analytics tooling - now is the time. R and Shiny are rising in popularity as data science teams see more value in R programming.